medline.ch Dermatologie Tumoren Anderes

	Interplay Between Immune Microenvironment CD8(+) Tumor-Infiltrating Lymphocytes and PDL-1 Expression as Prognostic Markers in Invasive Cervical Squamous Cell Carcinoma. Medicina (Kaunas) Petric, Deacu M, Cozaru GC, Mitroi AF, B, Enciu M, Cojocaru O, Nicolau AA, Baz AR, , A. PMID: 41303843 [PubMed - indexed for MEDLINE]
	Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions. Medicina (Kaunas) Steel HC, Rossouw TM, Anderson R, Anderson L, van Tonder D, Smit T, Rapoport BL. PMID: 41303751 [PubMed - indexed for MEDLINE]
	Prevalence of Torque Teno Virus (TTV) in Cervical Precursor Lesions and Cancer in Chilean Women. Int J Mol Sci Guzmán-Venegas M, Moreno-León C, Andrade-Madrigal C, Román A, Blanco R, Gallegos I, Aguayo F. PMID: 41303521 [PubMed - indexed for MEDLINE]
	Immunohistochemical Study of GATA3, c-KIT/CD117, CD56 and CD45 Expression in Proliferative Verrucous Leukoplakia (PVL), PVL-Associated Oral Squamous Cell Carcinoma and Oral Leukoplakia. Genes (Basel) Kalogirou EM, Katsoulas N, Goutas D, Vasili K, Mikoglou E, Tzanavari T, Tosios KI. PMID: 41300727 [PubMed - indexed for MEDLINE]
	Exocrine pancreatic insufficiency in a patient with regionally recurrent cutaneous squamous cell carcinoma undergoing treatment with cemiplimab. BMJ Case Rep Albuja Altamirano MF, O'Loughlin L, Patell R, Drews R. PMID: 41298244 [PubMed - indexed for MEDLINE]
	Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy. Tomography Liu L, Zeng C, Liu L, Zhou S, Wu W, Lin P, Fu J, Rong T, Zhang X, Su X. PMID: 41295564 [PubMed - indexed for MEDLINE]
	Machine learning-based clinical-radiomics model for predicting recurrence risk after radical surgery in sinonasal squamous cell carcinoma: a preliminary 2-year follow-up study. BMC Med Imaging Geng Y, Cheng J, Shen D, Wang Y, Kuang J, Tang Z. PMID: 41291508 [PubMed - indexed for MEDLINE]
	Efficacy and safety analysis of immune checkpoint inhibitor rechallenge in advanced esophageal squamous cell carcinoma: A retrospective study. Hum Vaccin Immunother Guo L, Wang M, Cao G, Wang X, Yan F, Qian T, Liu D. PMID: 41287859 [PubMed - indexed for MEDLINE]
	Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma. J Transl Med Han X, Sun T, Dai Y, Yun R, Wang H, Jia J, Feng X, Jiao M, Hou M, Yue M, Jiang S, Zhang G, An Y, Wang D. PMID: 41286896 [PubMed - indexed for MEDLINE]
	TRIM21 knockdown suppresses ESCC progression and induces autophagy-mediated apoptosis via AKT/mTOR signaling pathway. Int Immunopharmacol Ma S, Wang Y, Feng Y, Liu X, Liu S, Cheng B, Wang L. PMID: 41283348 [PubMed - indexed for MEDLINE]
	Clinicopathological profile of clear cell oral squamous cell carcinoma: a systematic review. Oral Maxillofac Surg Gonçalves MWA, Ferreira IV, Maciel TF, Egal ESA, Altemani A, Mariano FV. PMID: 41276702 [PubMed - indexed for MEDLINE]
	Three-field lymph node dissection subsequent to neoadjuvant concurrent chemoradiotherapy in esophageal cancer. Dis Esophagus Na B, Kang CH, Park JH, Na KJ, Park S, Park IK, Kim YT. PMID: 41275374 [PubMed - indexed for MEDLINE]
	Location characteristics of superficial esophageal squamous cell carcinoma. Sci Rep Ryu DG, Choi CW, Kim SY, Kim SJ, Park SB, Jang JO, Kim WJ, Son BS. PMID: 41272168 [PubMed - indexed for MEDLINE]
	Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial. Nat Commun Peng F, Wu J, Lian H, Wu S, Niu S, Xing X, Yang W, Song W, Li Y, Yu H, Feng ST, Wang X, Chen W, Ye W, Yu T, Liufu W, Cheng C, Bao Y. PMID: 41271680 [PubMed - indexed for MEDLINE]
	Organoid-based two-step drug screening for rapid identification of chemotherapy-resistant oesophageal squamous cell carcinoma and alternative therapies. Clin Transl Med Shao CY, Ju S, Tong X, Hu K, Li Y, Zhu YX, Yang J, Li C, Xie YF, Cui Y, Deng WJ, Ding C, Qin SB, Zhao J. PMID: 41267460 [PubMed - indexed for MEDLINE]
	Correlation of nutritional support and immunonutritional indicators with prognosis and survival in esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy. Nutr J Hong H, He Y, Huang W, Li Y, Shen Y, Sun D, Qu Y. PMID: 41267055 [PubMed - indexed for MEDLINE]
	Prognostic Factors in Patients With Locally Advanced Hypopharyngeal Squamous Cell Carcinoma After Radical Radiotherapy/Chemoradiotherapy. Cancer Med Qu X, Zhao Z, Wu Y, Qiu R, Song M, Wang Z, Liu Q, Zhao Y, Wang Y. PMID: 41264384 [PubMed - indexed for MEDLINE]
	Sequential CO(2) Laser and 5-Fluorouracil for Palliative Management of Cutaneous Squamous Cell Carcinoma. Australas J Dermatol Taibo A, Martín I, Paradela S, Del Pozo Losada J. PMID: 41263781 [PubMed - indexed for MEDLINE]
	Preoperative Diagnostic Value of Spectral CT for Predicting Perineural Invasion in Esophageal Cancer. Cancer Med Li Z, Lu W, Zhou Y, Wu X, Ge Y, Shao W, Hu S. PMID: 41263456 [PubMed - indexed for MEDLINE]
	Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy. Int J Nanomedicine Zhu X, Chen J, Zhao J, Zhang Z, Wang C. PMID: 41255464 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 2298

Seite 1 von 115

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung